Recommendations developed for pediatric NAFLD

Recommendations developed for pediatric NAFLD

(HealthDay)—Evidence-based recommendations have been developed for screening, diagnosis, and treatment of pediatric nonalcoholic fatty liver disease (NAFLD). The guidelines were published online Nov. 30 in the Journal of Pediatric Gastroenterology and Nutrition.

Miriam B. Vos, M.D., M.S.P.H., from Emory University in Atlanta, and colleagues conducted a comprehensive literature review to make evidence-based recommendations for management of pediatric NAFLD.

The researchers included key recommendations relating to screening, diagnosis, treatment, and long-term care of NAFLD. NAFLD screening should be conducted in all obese children aged 9 to 11 years and in children with specific . Alanine aminotransferase can be used for screening. Diagnosis of NAFLD necessitates further testing to determine whether steatosis is present and assess causes. Liver biopsy may be needed to check for more advanced disease. Lifestyle changes are the first treatment option; weight loss may reduce fatty deposits. There is no evidence for benefits of medications or supplements for NAFLD. For some adolescents with severe obesity and related health conditions, weight-loss surgery may be considered. Ongoing care should include assessment of other obesity-related diseases and management of , avoidance of potential liver toxins, and awareness of possible psychosocial issues.

"[NAFLD] has rapidly evolved into the most common seen in the pediatric population and is a management challenge for general pediatric practitioners, subspecialists, and for health systems," the authors write.

Several authors disclosed financial ties to the biopharmaceutical industry.


Explore further

Obese children should be screened for non-alcoholic fatty liver disease—new NASPGHAN guidelines

More information: Full Text (subscription or payment may be required)

Copyright © 2016 HealthDay. All rights reserved.

Citation: Recommendations developed for pediatric NAFLD (2016, December 13) retrieved 15 August 2020 from https://medicalxpress.com/news/2016-12-pediatric-nafld.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments